An increasingly complex code
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
The nucleosome core particle is the fundamental unit of chromatin structure in all eukaryotes. It comprises eight core histones (two each of H2A, H2B, H3, and H4) around which are wrapped 146 bp of DNA, and its structure has been defined at 2.8 Å resolution by x-ray crystallography (1). Since it was first described, it has been assumed that the function of the core particle is to package DNA into the interphase cell nucleus and metaphase chromosomes. Wrapping DNA around the histone octamer in left-handed supercoils results in an approximately sevenfold reduction in its length. Although this is only a small fraction of the several-thousand-fold length reduction required for compaction into metaphase chromosomes, it is presumably an essential first step that enables higher-order structures to assemble. The nucleosome’s rather mundane packaging job became more interesting with the realization that compaction of DNA into chromatin is a crucial element in eukaryotic gene regulation (2). Appropriately located nucleosomes can hinder assembly of transcription initiation complexes and polymerase progression, and over recent years, whole families of chromatin-remodeling enzymes have been identified whose primary purpose is to reorganize histone-DNA interactions so as to facilitate (or repress) transcription (3). These enzymes disrupt the nucleosome in an ATP-dependent manner that often results in movement of the histone core relative to the DNA, thereby exposing recognition sequences for DNA-binding activators or repressors. However, even these insights still left the nucleosome as a passive inhibitor of transcription, something to be moved aside so transcription could proceed. The final transformation of the nucleosome into a truly exciting and colorful character has come through studies on the effects and properties of other enzymes that act on chromatin. It has been known for many years that the histone N-terminal tails are exposed on the surface of the nucleosome and that selected amino acid residues are subject to a variety of enzyme-catalyzed, posttranslational modifications. These include acetylation of lysines, phosphorylation of serines, and methylation of lysines and arginines. The locations of the histone N-terminal tails in the nucleosome and the residues that can be modified are shown in Figure Figure1.1. The function of these modifications, and indeed of the tails themselves, is the focus of much current attention, centered largely on the possibility that the nucleosome, with its modified tail domains, is not just a humble packer of DNA, but a carrier of epigenetic information that determines both how genes are expressed and how their expression patterns are maintained from one cell generation to the next. Figure 1 A nucleosome core particle, showing the core histone N-terminal tail domains and sites of posttranslational modification. Residue numbers for modified residues are shown. Note that H3 lysine 9 (star) can be either acetylated or methylated. The C-terminal ...
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
DNA methylation patterns and epigenetic memory
Bird, A. (2002) · Genes & Development · doi:10.1101/gad.947102 · Cited by 7,124 · cited 1×
“The methyl DNA-binding protein MeCP2 can bind histone deacetylases, thereby targeting them to methylated DNA and resulting in local histone deacetylation and suppression of transcription (14).”
BackgroundSelective recognition of methylated lysine 9 on histone H3 by the HP1 chromo domain
Bannister, A. J., Zegerman, P., Partridge, J. F., Miska, E. A., Thomas, J. O., Allshire, R. C., & Kouzarides, T. (2001) · Nature · doi:10.1038/35065138 · Cited by 2,903
Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins
Lachner, M., O'Carroll, D., Rea, S., Mechtler, K., & Jenuwein, T. (2001) · Nature · doi:10.1038/35065132 · Cited by 2,868 · cited 1×
“The mammalian enzymes SUV39H1 and SUV39H2 have been shown to locate to constitutive heterochromatin, which also, by immunofluorescent labeling, appears to be relatively rich in H3 methylated at lysine 9 (33, 34).”
BackgroundRegulation of chromatin structure by site-specific histone H3 methyltransferases
Rea, S., Eisenhaber, F., O'Carroll, D., Strahl, B. D., Sun, Z.-W., Schmid, M., Opravil, S., Mechtler, K., Ponting, C. P., Allis, C. D., et al. (2000) · Nature · doi:10.1038/35020506 · Cited by 2,845
Histone deacetylases and cancer: causes and therapies
Marks, P. A., Rifkind, R. A., Richon, V. M., Breslow, R., Miller, T., & Kelly, W. K. (2001) · Nature reviews. Cancer · doi:10.1038/35106079 · Cited by 1,866 · cited 1×
“Some of these agents have proved to be remarkably effective at selectively inhibiting the growth of human tumor cells, and several are now in clinical trials against a variety of tumor types (51).”
BackgroundSignaling to Chromatin through Histone Modifications
Cheung, P., Allis, C. D., & Sassone-Corsi, P. (2000) · Cell · doi:10.1016/s0092-8674(00)00118-5 · Cited by 989
Tachibana, M., Sugimoto, K., Fukushima, T., & Shinkai, Y. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101914200 · Cited by 784
Ng (2000) · doi:10.1016/s0968-0004(00)01551-6 · Cited by 427
Regulation of histone deacetylase 2 by protein kinase CK2
Tsai, S.-C., & Seto, E. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204149200 · Cited by 196 · cited 1×
“For example, HDACs are phosphorylated in vivo by protein kinases such as CK2 in ways that influence both their catalytic activity and their ability to interact with other proteins in functional complexes (54, 55).”
BackgroundJohnson, C. A., White, D. A., Lavender, J. S., O'Neill, L. P., & Turner, B. M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m107942200 · Cited by 119 · cited 11×
“Conversely, where levels of gene expression are to be stably maintained over long periods, patterns of histone modification are stabilized by removing (or inhibiting) the HATs and HDACs targeted to that genomic region.”
BackgroundInfluentialSelf-citation
Cited by
Cellular Memory and the Histone Code
Turner, B. M. (2002) · Cell · doi:10.1016/s0092-8674(02)01080-2 · Cited by 1,142
Self-citationBorkovich, K. A., Alex, L. A., Yarden, O., Freitag, M., Turner, G. E., Read, N. D., Seiler, S., Bell-Pedersen, D., Paietta, J., Plesofsky, N., et al. (2004) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.68.1.1-108.2004 · Cited by 621
Gui, C.-Y., Ngo, L., Xu, W. S., Richon, V. M., & Marks, P. A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307708100 · Cited by 550
CLINICAL DEVELOPMENT OF HISTONE DEACETYLASE INHIBITORS AS ANTICANCER AGENTS
Drummond, D. C., Noble, C. O., Kirpotin, D. B., Guo, Z., Scott, G. K., & Benz, C. C. (2005) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.45.120403.095825 · Cited by 494
Prospects: Histone deacetylase inhibitors
Dokmanovic, M., & Marks, P. A. (2005) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20532 · Cited by 479
Metadata
- Authors
- Spotswood, H. T., & Turner, B. M.
- Venue
- Journal of Clinical Investigation
- Published
- 2002-09-01
- Volume
- 110
- Issue
- 5
- Pages
- 577-582
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W1998749998
- Cited by
- 122
- References
- 10
- FWCI
- 3.78
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: An increasingly complex code. https://app.cochat.ai/papers/10.1172/jci16547
- The paper
- Spotswood, H. T., & Turner, B. M. (2002). An increasingly complex code. Journal of Clinical Investigation. https://doi.org/10.1172/jci16547
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.